首页> 外文期刊>Analytical methods >Development of an ultra fast online-solid phase extraction (SPE) liquid chromatography electrospray tandem mass spectrometry (LC-ESI-MS/MS) based approach for the determination of drugs in pharmacokinetic studiest
【24h】

Development of an ultra fast online-solid phase extraction (SPE) liquid chromatography electrospray tandem mass spectrometry (LC-ESI-MS/MS) based approach for the determination of drugs in pharmacokinetic studiest

机译:开发一种基于超快速在线固相萃取(SPE)液相色谱电喷雾串联质谱(LC-ESI-MS / MS)的方法来测定药代动力学研究中的药物

获取原文
获取原文并翻译 | 示例
           

摘要

High-throughput analyses of a large number of samples for pharmacokinetic (PK) studies are essential in drug development. Analysis of drug candidates from blood using LC-ESI-MS generally requires separation of the plasma fraction followed by various offline sample preparation procedures. This step is a bottleneck that impedes throughput. In order to overcome this difficulty and accelerate analysis in PK and other studies, we developed an approach allowing the direct analysis of low volumes of whole blood (10 μL) after dilution and centrifugation. Samples were injected in an online-SPE-LC-ESI-MS/ MS setup allowing a total run time of only 126 s for a full gradient separation. Analytes were extracted from the matrix within 30 s by turbulent flow chromatography. Subsequently, a full gradient separation was carried out within 1.5 minutes on a 50 x 2.1 mm (1.7 μm) RP-18 column and the analytes were sensitively detected by ESI-MS/MS in SRM mode. The performance of this new ultra fast online SPE-LC-ESI-MS/MS approach was demonstrated by the analysis of diclofenac (DCF), a widely used anti-inflammatory drug. DCF eluted at stable retention times (±0.33%) with narrow peak width (FWHM 3.3 ± 0.15 s). The method displays excellent analytical performance, with a limit of detection of 6 fmol on column, a linear range of over four orders of magnitude and a negligible carry over of 0.12 ± 0.03% for DCF. The PK profile of DCF administered by topical and intraperitoneal routes in rats and by oral route in one human volunteer is investigated using this method. Finally, general applicability of the approach for drugs is demonstrated by analysis of rofecoxib and several inhibitors of the soluble epoxide hydrolase. This new method requires only readily available, off the shelf standard LC instrumentation, and is compliant with the requirements of green analytical chemistry.
机译:对大量样品进行药代动力学(PK)研究的高通量分析对于药物开发至关重要。使用LC-ESI-MS从血液中分析候选药物通常需要分离血浆部分,然后进行各种离线样品制备程序。此步骤是阻碍吞吐量的瓶颈。为了克服这一困难并加速PK和其他研究的分析,我们开发了一种方法,允许在稀释和离心后直接分析少量的全血(10μL)。样品以在线SPE-LC-ESI-MS / MS设置进样,全梯度分离的总运行时间仅为126 s。通过湍流色谱法在30 s内从基质中提取分析物。随后,在50 x 2.1 mm(1.7μm)RP-18色谱柱上在1.5分钟内进行完全梯度分离,并通过ESI-MS / MS在SRM模式下灵敏地检测了分析物。通过分析广泛使用的抗炎药双氯芬酸(DCF),证明了这种新型超快速在线SPE-LC-ESI-MS / MS方法的性能。 DCF以稳定的保留时间(±0.33%)和窄的峰宽(FWHM 3.3±0.15 s)洗脱。该方法具有出色的分析性能,在色谱柱上的检出限为6 fmol,线性范围超过四个数量级,DCF的残留率可忽略不计0.12±0.03%。使用这种方法研究了通过局部和腹膜内途径在大鼠中以及通过口服途径在一名人类志愿者中施用的DCF的PK谱。最后,通过对罗非考昔和几种可溶性环氧化物水解酶抑制剂的分析证明了该方法在药物中的普遍适用性。这种新方法仅需使用现成的标准LC仪器即可,并且符合绿色分析化学的要求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号